Report Categories Report Categories

Report Categories

industry Category

All

Total: 4 records, 1 pages

Global Recombinant Human Interferon α1b Supply, Demand and Key Producers, 2024-2030

date 03 Mar 2024

date Pharma & Healthcare

new_biaoQian Recombinant Human Interferon α1b

The global Recombinant Human Interferon α1b market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Recombinant Human Interferon α1b Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

new_biaoQian Recombinant Human Interferon α1b

According to our (Global Info Research) latest study, the global Recombinant Human Interferon α1b market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

Add To Cart

Global Recombinant Human Interferon α1b Supply, Demand and Key Producers, 2023-2029

date 03 Feb 2023

date Pharma & Healthcare

new_biaoQian Recombinant Human Interferon α1b

The global Recombinant Human Interferon α1b market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

Global Recombinant Human Interferon α1b Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 11 Jan 2023

date Pharma & Healthcare

new_biaoQian Recombinant Human Interferon α1b

Recombinant human interferon α1b for injection is suitable for the treatment of viral diseases and certain malignant tumors. It has been approved for the treatment of chronic hepatitis B, hepatitis C and hairy cell leukemia. The results of clinical trials and literature reports have been effective in the treatment of viral diseases such as herpes zoster, condyloma acuminatum, epidemic hemorrhagic fever and pediatric respiratory syncytial virus pneumonia, and can be used to treat malignant tumors such as chronic myeloid leukemia, melanoma, Lymphoma and so on.

USD3480.00

Add To Cart

Add To Cart

industry 03 Mar 2024

industry Pharma & Healthcare

new_biaoQian Recombinant Human Interferon α1b

The global Recombinant Human Interferon α1b market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 10 Jan 2024

industry Pharma & Healthcare

new_biaoQian Recombinant Human Interferon α1b

According to our (Global Info Research) latest study, the global Recombinant Human Interferon α1b market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

addToCart

Add To Cart

industry 03 Feb 2023

industry Pharma & Healthcare

new_biaoQian Recombinant Human Interferon α1b

The global Recombinant Human Interferon α1b market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart

industry 11 Jan 2023

industry Pharma & Healthcare

new_biaoQian Recombinant Human Interferon α1b

Recombinant human interferon α1b for injection is suitable for the treatment of viral diseases and certain malignant tumors. It has been approved for the treatment of chronic hepatitis B, hepatitis C and hairy cell leukemia. The results of clinical trials and literature reports have been effective in the treatment of viral diseases such as herpes zoster, condyloma acuminatum, epidemic hemorrhagic fever and pediatric respiratory syncytial virus pneumonia, and can be used to treat malignant tumors such as chronic myeloid leukemia, melanoma, Lymphoma and so on.

USD3480.00

addToCart

Add To Cart